Tenaya Therapeutics, Inc.
TNYA
$0.4111
-$0.0028-0.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.86M | -23.84M | -25.63M | -29.43M | -32.23M |
| Total Depreciation and Amortization | 2.66M | 2.09M | 2.10M | 2.12M | 2.16M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.53M | 4.40M | 5.01M | 5.63M | 5.05M |
| Change in Net Operating Assets | -3.44M | -1.04M | -1.32M | -1.94M | -3.64M |
| Cash from Operations | -23.11M | -18.39M | -19.84M | -23.62M | -28.66M |
| Capital Expenditure | -383.00K | -204.00K | -184.00K | -73.00K | -564.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.69M | 14.31M | -29.91M | 21.69M | -3.93M |
| Cash from Investing | 22.30M | 14.10M | -30.10M | 21.62M | -4.49M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 50.26M | 377.00K | 31.00K | 570.00K | 46.77M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 50.26M | 377.00K | 31.00K | 570.00K | 46.77M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 49.45M | -3.91M | -49.90M | -1.43M | 13.62M |